Pharmaceutical company Adcock Ingram is considering exports to the Asia-Pacific and South America as it looks to build its international business, CEO Andy Hall says. While growing the business in other parts of Africa was an immediate focus, Hall said the company was "starting to look outside of the continent at some potential distributorships". "Maybe within a year or so we will be able to give feedback on those initiatives," Hall said in an interview on Wednesday. There could be opportunities to export consumer brands to Australia and Southeast Asia, while a number of South American countries were potentially attractive "if we can get over regulatory hurdles". The group remains highly concentrated on the South African market, though it has a relatively small but fast-growing rest-of-Africa business. Its businesses in Zimbabwe and Kenya account for about 4% of sales while exports to other African countries make up another 3% of turnover. Expansion "is certainly a focus for us", Ha...

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as exclusive Financial Times articles, ProfileData financial data, and digital access to the Sunday Times and Times Select.

Already subscribed? Simply sign in below.

Questions or problems? Email or call 0860 52 52 00. Got a subscription voucher? Redeem it now